Today’s state of the art sterility testing relies on decades old microbiology taking 7-14 days which adds a substantial delay in the creation of life-saving cell therapies. Using Prophesee Metavision sensor and AI models to detect, track and classify cells, Cambridge Consultants was able to build an automated sterility testing system, cutting down required testing time from weeks to milliseconds.

READ MORE

Nature Medicine published the first case report of partial recovery of visual function in a blind patient with late stage retinitis pigmentosa (RP). 

The study combines gene therapy with a light-stimulating medical device in the form of goggles that uses Prophesee Metavision® Sensor. “The light-stimulating goggles capture images from the visual world using a neuromorphic camera that detects changes in intensity, pixel by pixel, as distinct events.”

READ MORE

Aided by Prophesee’s Metavision sensing technologies, researchers at the University of Glasgow, Heriot-Watt University, and the University of Strathclyde have discovered ways to leverage Event-Based Vision’s high-speed particle detection capabilities to perform microfluidic analysis.

This enables the detection of particles of size down to 1 µm, and a wide range of fluid velocities, up to 1.54 m/s.

READ MORE